Trust Co. of Vermont Has $997,000 Position in Cardinal Health, Inc. (NYSE:CAH)

Trust Co. of Vermont reduced its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 8.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,887 shares of the company’s stock after selling 945 shares during the quarter. Trust Co. of Vermont’s holdings in Cardinal Health were worth $997,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the stock. Aviva PLC increased its stake in shares of Cardinal Health by 2.1% in the third quarter. Aviva PLC now owns 96,490 shares of the company’s stock valued at $8,377,000 after buying an additional 2,009 shares in the last quarter. Johnson Investment Counsel Inc. increased its position in Cardinal Health by 6.8% in the third quarter. Johnson Investment Counsel Inc. now owns 6,201 shares of the company’s stock worth $538,000 after purchasing an additional 397 shares during the period. Kestra Advisory Services LLC increased its position in Cardinal Health by 20.6% in the third quarter. Kestra Advisory Services LLC now owns 16,411 shares of the company’s stock worth $1,425,000 after purchasing an additional 2,798 shares during the period. Rafferty Asset Management LLC increased its position in Cardinal Health by 7.8% in the third quarter. Rafferty Asset Management LLC now owns 26,564 shares of the company’s stock worth $2,306,000 after purchasing an additional 1,924 shares during the period. Finally, Korea Investment CORP increased its position in Cardinal Health by 70.0% in the third quarter. Korea Investment CORP now owns 147,477 shares of the company’s stock worth $12,804,000 after purchasing an additional 60,728 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

NYSE CAH traded down $0.51 during trading on Monday, hitting $99.69. The stock had a trading volume of 194,748 shares, compared to its average volume of 2,156,834. The company has a market capitalization of $24.28 billion, a PE ratio of 44.53, a P/E/G ratio of 1.13 and a beta of 0.64. The company’s 50-day moving average price is $100.81 and its two-hundred day moving average price is $104.81. Cardinal Health, Inc. has a 12 month low of $85.11 and a 12 month high of $116.04.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, May 2nd. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $1.95 by $0.13. The firm had revenue of $54.90 billion for the quarter, compared to analyst estimates of $56.05 billion. Cardinal Health had a negative return on equity of 54.74% and a net margin of 0.25%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.74 EPS. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 7.35 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Investors of record on Monday, July 1st will be issued a dividend of $0.5056 per share. The ex-dividend date is Monday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.50. This represents a $2.02 dividend on an annualized basis and a dividend yield of 2.03%. Cardinal Health’s payout ratio is presently 88.89%.

Wall Street Analyst Weigh In

A number of brokerages recently commented on CAH. Wells Fargo & Company lowered their price objective on Cardinal Health from $96.00 to $94.00 and set an “underweight” rating for the company in a research report on Monday, April 29th. Robert W. Baird lowered their price objective on Cardinal Health from $134.00 to $128.00 and set an “outperform” rating for the company in a research report on Friday, May 3rd. StockNews.com lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, May 28th. Evercore ISI raised their target price on Cardinal Health from $110.00 to $115.00 and gave the stock an “in-line” rating in a report on Friday, May 3rd. Finally, Leerink Partnrs restated an “outperform” rating on shares of Cardinal Health in a report on Monday, February 26th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and an average target price of $109.67.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.